What tests are necessary to diagnose amenorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Amenorrhea

The essential tests to diagnose amenorrhea include a pregnancy test (urine hCG), serum prolactin, thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH), followed by a progesterone challenge test if initial labs are normal. 1, 2

Initial Mandatory Laboratory Tests

All patients presenting with amenorrhea require the following baseline tests:

  • Pregnancy test (urine or serum hCG) - Must be performed first to exclude pregnancy, the most common cause of amenorrhea 1, 3, 4
  • Serum prolactin level - To identify hyperprolactinemia and potential pituitary adenoma 1, 2, 4
  • Thyroid-stimulating hormone (TSH) - To detect thyroid dysfunction 1, 2, 4
  • Follicle-stimulating hormone (FSH) - To differentiate ovarian failure from hypothalamic/pituitary dysfunction 1, 2
  • Luteinizing hormone (LH) - To assess gonadotropin status and identify patterns suggestive of polycystic ovary syndrome 1, 2

History and Physical Examination Components

The clinical evaluation must include specific targeted elements:

Menstrual and reproductive history:

  • Age at menarche, cycle length and characteristics, onset/severity of dysmenorrhea 5
  • Gravidity, parity, pregnancy outcomes and complications 5
  • Duration of amenorrhea (primary vs. secondary) 1, 2

Review of systems emphasizing:

  • Symptoms of thyroid disease, galactorrhea, hirsutism 5
  • Pelvic or abdominal pain, dyspareunia 5
  • Eating and exercise habits, psychosocial stressors, body weight changes 2
  • Vasomotor symptoms (hot flashes suggesting hypoestrogenism) 2

Physical examination must include:

  • Height, weight, and BMI calculation 5
  • Thyroid examination for enlargement, nodules, or tenderness 5
  • Clinical breast examination and assessment for galactorrhea 5
  • Assessment for signs of androgen excess (hirsutism, acne) 5
  • Pelvic examination when indicated (see below) 5

Progesterone Challenge Test

If pregnancy test, prolactin, and TSH are normal:

  • Administer progesterone (medroxyprogesterone acetate 10 mg daily for 5-10 days) to determine outflow tract patency and estrogen status 4
  • Positive test (withdrawal bleeding occurs) indicates adequate estrogen and patent outflow tract, suggesting anovulation (commonly polycystic ovary syndrome) 4
  • Negative test (no bleeding) indicates either hypoestrogenism or outflow tract obstruction 4

Additional Testing Based on Initial Results

If prolactin is elevated:

  • Brain MRI to evaluate for pituitary adenoma 6, 2

If TSH is abnormal:

  • Complete thyroid function panel (free T4) 2

If FSH is elevated (>40 mIU/mL):

  • Indicates primary ovarian insufficiency 1, 2
  • Karyotype analysis if patient is under 30 years old to identify Turner syndrome or other chromosomal abnormalities 1, 2

If FSH is low or normal with negative progesterone challenge:

  • Suggests hypothalamic or pituitary dysfunction 1, 4
  • Consider evaluation for functional hypothalamic amenorrhea (eating disorders, excessive exercise, stress) 2, 4

If hyperandrogenism is suspected clinically:

  • Serum testosterone, DHEA-sulfate, and 17-hydroxyprogesterone 2

Imaging Studies

Pelvic ultrasound indications:

  • Primary amenorrhea with absent uterus (to confirm Müllerian agenesis) 3
  • Suspected polycystic ovary syndrome 2
  • Evaluation for outflow tract obstruction 5

When pelvic examination is necessary:

  • Primary amenorrhea to assess for anatomic abnormalities (imperforate hymen, transverse vaginal septum) 5, 3
  • Suspected outflow tract obstruction 5
  • Note: Pelvic examination is NOT required before initiating most hormonal contraceptives 5

Bone Density Assessment

DXA scan indications in amenorrheic patients:

  • History of amenorrhea ≥6 months with low energy availability, eating disorder, or BMI <17.5 kg/m² 5
  • History of stress fractures 5
  • Athletes with oligomenorrhea/amenorrhea and other Female Athlete Triad risk factors 5

Sites to scan:

  • Adults ≥20 years: posteroanterior lumbar spine, total hip, femoral neck 5
  • Adolescents <20 years: posteroanterior lumbar spine and whole body (head excluded) 5

Common Pitfalls to Avoid

  • Never skip the pregnancy test - even in patients who deny sexual activity, as this is the most common cause of amenorrhea 1, 3, 4
  • Do not order all tests simultaneously - follow the algorithmic approach to avoid unnecessary testing and cost 1, 2
  • Do not assume infertility - patients with primary ovarian insufficiency can maintain unpredictable ovarian function 1, 2
  • Do not overlook eating disorders - functional hypothalamic amenorrhea requires specific evaluation for disordered eating and carries risk for decreased bone density 1, 2

References

Research

Amenorrhea: an approach to diagnosis and management.

American family physician, 2013

Research

Amenorrhea: evaluation and treatment.

American family physician, 2006

Research

Evaluation of amenorrhea.

American family physician, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the approach to investigating amenorrhea (absence of menstruation) in a patient?
What is the management approach for a 29-year-old female with amenorrhea and inconsistent menstrual cycles, and a negative pregnancy test?
What is the appropriate evaluation and treatment for a patient with amenorrhea and normal breast development?
What is the next step in management for a 27-year-old woman with amenorrhea (absence of menstruation) for 2 months, negative pregnancy test, normal transvaginal ultrasound, and obesity, with normal laboratory results?
What are the treatment options for amenorrhea (absence of menstruation)?
What medications, such as Megace (megesterol acetate) or Oxandrin (oxandrolone), can be used to enhance appetite in a patient with decreased appetite after a fever, in the absence of any underlying medical conditions?
Is diosmin + hesperidin (flavonoid combination) warranted for a patient with bleeding, likely from hemorrhoids?
What is the best treatment approach for a patient with myxedema coma in the Intensive Care Unit (ICU)?
What is the role of the MACOCHA (Mallampati class, Age, Comorbidities, Obesity, History of difficult airway, Cormack grade, and other clinical variables) score in assessing the risk of difficult intubation in a critically ill patient with myxedema coma?
Is a 2-week regimen of diosmin + hesperidin sufficient for a patient with bleeding hemorrhoids, particularly those with a history of recurrent hemorrhoids?
What are the prevention, diagnosis, and management strategies for a pregnant woman at risk of eclampsia, particularly those with a history of hypertension or other risk factors?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.